Table 2.
cCVDR | Std risk | p Value* | |
All (n = 89) | 20.6 (1.2) | 15.7 (1.1) | 0.009 |
Males (n = 47) | 23.5 (1.1) | 19.1 (1.1) | 0.120 |
Females (n = 42 ) | 17.8 (1.2) | 12.7 (1.0) | 0.022 |
*t test after logarithmic transformation to normalise the data.
% males with cCVDR ≥20 = 66%.
% females with cCVDR ≥20 = 54.8%.